Search

Your search keyword '"Harding, James J."' showing total 106 results
Start Over Author "Harding, James J." Publisher american association for cancer research (aacr)
106 results on '"Harding, James J."'

10. Supplementary Figure 1 from A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors

Author

Garmezy, Benjamin, primary, Borad, Mitesh J., primary, Bahleda, Rastilav, primary, Perez, Cesar A., primary, Chen, Li-Tzong, primary, Kato, Shumei, primary, Oh, Do-Youn, primary, Severson, Paul, primary, Tam, Betty Y., primary, Quah, Cheng S., primary, and Harding, James J., primary

Published
2024
Full Text
View/download PDF

12. Supplementary Figure 4 from A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors

Author

Garmezy, Benjamin, primary, Borad, Mitesh J., primary, Bahleda, Rastilav, primary, Perez, Cesar A., primary, Chen, Li-Tzong, primary, Kato, Shumei, primary, Oh, Do-Youn, primary, Severson, Paul, primary, Tam, Betty Y., primary, Quah, Cheng S., primary, and Harding, James J., primary

Published
2024
Full Text
View/download PDF

14. Supplementary Figure 3 from A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors

Author

Garmezy, Benjamin, primary, Borad, Mitesh J., primary, Bahleda, Rastilav, primary, Perez, Cesar A., primary, Chen, Li-Tzong, primary, Kato, Shumei, primary, Oh, Do-Youn, primary, Severson, Paul, primary, Tam, Betty Y., primary, Quah, Cheng S., primary, and Harding, James J., primary

Published
2024
Full Text
View/download PDF

18. Abstract CT098: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced IDH-mutant cholangiocarcinoma and other solid tumors

Author

Rodon, Jordi, primary, Goyal, Lipika, additional, Mercade, Teresa Macarulla, additional, Ikeda, Masafumi, additional, Kondo, Shunsuke, additional, Oh, Do-Youn, additional, Bai, Li-Yuan, additional, Ueno, Makoto, additional, Italiano, Antoine, additional, Papadopoulos, Kyriakos, additional, Spigel, David, additional, Kizilbash, Sani H., additional, Cosman, Rasha, additional, Park, Joon Oh, additional, Chen, Li-Tzong, additional, Yokota, Tomoya, additional, Turk, Anita A., additional, Liao, Chih-Yi, additional, Shroff, Rachna, additional, El-Khoueiry, Anthony, additional, Satoh, Taroh, additional, Hollebecque, Antoine, additional, Borad, Mitesh J., additional, Azad, Nilofer, additional, Jaeckle, Kurt A., additional, Loong, Herbert H., additional, Adeva, Jorge, additional, Yong, Wei Peng, additional, Zhao, Junjie, additional, Liu, Hui, additional, Szpurka, Anna M., additional, Gueorguieva, Ivelina, additional, Pradhan, Kamnesh R., additional, Xu, Xiaojian, additional, and Harding, James J., additional

Published
2023
Full Text
View/download PDF

19. Data from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

20. Table S1 from TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Author

Goyal, Lipika, primary, Shi, Lei, primary, Liu, Leah Y., primary, Fece de la Cruz, Ferran, primary, Lennerz, Jochen K., primary, Raghavan, Srivatsan, primary, Leschiner, Ignaty, primary, Elagina, Liudmila, primary, Siravegna, Giulia, primary, Ng, Raymond W.S., primary, Vu, Phuong, primary, Patra, Krushna C., primary, Saha, Supriya K., primary, Uppot, Raul N., primary, Arellano, Ron, primary, Reyes, Stephanie, primary, Sagara, Takeshi, primary, Otsuki, Sachie, primary, Nadres, Brandon, primary, Shahzade, Heather A., primary, Dey-Guha, Ipsita, primary, Fetter, Isobel J., primary, Baiev, Islam, primary, Van Seventer, Emily E., primary, Murphy, Janet E., primary, Ferrone, Cristina R., primary, Tanabe, Kenneth K., primary, Deshpande, Vikram, primary, Harding, James J., primary, Yaeger, Rona, primary, Kelley, Robin K., primary, Bardelli, Alberto, primary, Iafrate, A. John, primary, Hahn, William C., primary, Benes, Cyril H., primary, Ting, David T., primary, Hirai, Hiroshi, primary, Getz, Gad, primary, Juric, Dejan, primary, Zhu, Andrew X., primary, Corcoran, Ryan B., primary, and Bardeesy, Nabeel, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figures from Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition

Author

Harding, James J., primary, Lowery, Maeve A., primary, Shih, Alan H., primary, Schvartzman, Juan M., primary, Hou, Shengqi, primary, Famulare, Christopher, primary, Patel, Minal, primary, Roshal, Mikhail, primary, Do, Richard K., primary, Zehir, Ahmet, primary, You, Daoqi, primary, Selcuklu, S. Duygu, primary, Viale, Agnes, primary, Tallman, Martin S., primary, Hyman, David M., primary, Reznik, Ed, primary, Finley, Lydia W.S., primary, Papaemmanuil, Elli, primary, Tosolini, Alessandra, primary, Frattini, Mark G., primary, MacBeth, Kyle J., primary, Liu, Guowen, primary, Fan, Bin, primary, Choe, Sung, primary, Wu, Bin, primary, Janjigian, Yelena Y., primary, Mellinghoff, Ingo K., primary, Diaz, Luis A., primary, Levine, Ross L., primary, Abou-Alfa, Ghassan K., primary, Stein, Eytan M., primary, and Intlekofer, Andrew M., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figure 1 from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

23. Data from TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Author

Goyal, Lipika, primary, Shi, Lei, primary, Liu, Leah Y., primary, Fece de la Cruz, Ferran, primary, Lennerz, Jochen K., primary, Raghavan, Srivatsan, primary, Leschiner, Ignaty, primary, Elagina, Liudmila, primary, Siravegna, Giulia, primary, Ng, Raymond W.S., primary, Vu, Phuong, primary, Patra, Krushna C., primary, Saha, Supriya K., primary, Uppot, Raul N., primary, Arellano, Ron, primary, Reyes, Stephanie, primary, Sagara, Takeshi, primary, Otsuki, Sachie, primary, Nadres, Brandon, primary, Shahzade, Heather A., primary, Dey-Guha, Ipsita, primary, Fetter, Isobel J., primary, Baiev, Islam, primary, Van Seventer, Emily E., primary, Murphy, Janet E., primary, Ferrone, Cristina R., primary, Tanabe, Kenneth K., primary, Deshpande, Vikram, primary, Harding, James J., primary, Yaeger, Rona, primary, Kelley, Robin K., primary, Bardelli, Alberto, primary, Iafrate, A. John, primary, Hahn, William C., primary, Benes, Cyril H., primary, Ting, David T., primary, Hirai, Hiroshi, primary, Getz, Gad, primary, Juric, Dejan, primary, Zhu, Andrew X., primary, Corcoran, Ryan B., primary, and Bardeesy, Nabeel, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 2 from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Tables and Legend from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure 3 from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

27. Figure S1 and S2 from TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Author

Goyal, Lipika, primary, Shi, Lei, primary, Liu, Leah Y., primary, Fece de la Cruz, Ferran, primary, Lennerz, Jochen K., primary, Raghavan, Srivatsan, primary, Leschiner, Ignaty, primary, Elagina, Liudmila, primary, Siravegna, Giulia, primary, Ng, Raymond W.S., primary, Vu, Phuong, primary, Patra, Krushna C., primary, Saha, Supriya K., primary, Uppot, Raul N., primary, Arellano, Ron, primary, Reyes, Stephanie, primary, Sagara, Takeshi, primary, Otsuki, Sachie, primary, Nadres, Brandon, primary, Shahzade, Heather A., primary, Dey-Guha, Ipsita, primary, Fetter, Isobel J., primary, Baiev, Islam, primary, Van Seventer, Emily E., primary, Murphy, Janet E., primary, Ferrone, Cristina R., primary, Tanabe, Kenneth K., primary, Deshpande, Vikram, primary, Harding, James J., primary, Yaeger, Rona, primary, Kelley, Robin K., primary, Bardelli, Alberto, primary, Iafrate, A. John, primary, Hahn, William C., primary, Benes, Cyril H., primary, Ting, David T., primary, Hirai, Hiroshi, primary, Getz, Gad, primary, Juric, Dejan, primary, Zhu, Andrew X., primary, Corcoran, Ryan B., primary, and Bardeesy, Nabeel, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure 3 from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figures from Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition

Author

Harding, James J., primary, Lowery, Maeve A., primary, Shih, Alan H., primary, Schvartzman, Juan M., primary, Hou, Shengqi, primary, Famulare, Christopher, primary, Patel, Minal, primary, Roshal, Mikhail, primary, Do, Richard K., primary, Zehir, Ahmet, primary, You, Daoqi, primary, Selcuklu, S. Duygu, primary, Viale, Agnes, primary, Tallman, Martin S., primary, Hyman, David M., primary, Reznik, Ed, primary, Finley, Lydia W.S., primary, Papaemmanuil, Elli, primary, Tosolini, Alessandra, primary, Frattini, Mark G., primary, MacBeth, Kyle J., primary, Liu, Guowen, primary, Fan, Bin, primary, Choe, Sung, primary, Wu, Bin, primary, Janjigian, Yelena Y., primary, Mellinghoff, Ingo K., primary, Diaz, Luis A., primary, Levine, Ross L., primary, Abou-Alfa, Ghassan K., primary, Stein, Eytan M., primary, and Intlekofer, Andrew M., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Methods from Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition

Author

Harding, James J., primary, Lowery, Maeve A., primary, Shih, Alan H., primary, Schvartzman, Juan M., primary, Hou, Shengqi, primary, Famulare, Christopher, primary, Patel, Minal, primary, Roshal, Mikhail, primary, Do, Richard K., primary, Zehir, Ahmet, primary, You, Daoqi, primary, Selcuklu, S. Duygu, primary, Viale, Agnes, primary, Tallman, Martin S., primary, Hyman, David M., primary, Reznik, Ed, primary, Finley, Lydia W.S., primary, Papaemmanuil, Elli, primary, Tosolini, Alessandra, primary, Frattini, Mark G., primary, MacBeth, Kyle J., primary, Liu, Guowen, primary, Fan, Bin, primary, Choe, Sung, primary, Wu, Bin, primary, Janjigian, Yelena Y., primary, Mellinghoff, Ingo K., primary, Diaz, Luis A., primary, Levine, Ross L., primary, Abou-Alfa, Ghassan K., primary, Stein, Eytan M., primary, and Intlekofer, Andrew M., primary

Published
2023
Full Text
View/download PDF

31. Supplementary Tables and Legend from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

32. Data from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

33. Figure S1 and S2 from TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Author

Goyal, Lipika, primary, Shi, Lei, primary, Liu, Leah Y., primary, Fece de la Cruz, Ferran, primary, Lennerz, Jochen K., primary, Raghavan, Srivatsan, primary, Leschiner, Ignaty, primary, Elagina, Liudmila, primary, Siravegna, Giulia, primary, Ng, Raymond W.S., primary, Vu, Phuong, primary, Patra, Krushna C., primary, Saha, Supriya K., primary, Uppot, Raul N., primary, Arellano, Ron, primary, Reyes, Stephanie, primary, Sagara, Takeshi, primary, Otsuki, Sachie, primary, Nadres, Brandon, primary, Shahzade, Heather A., primary, Dey-Guha, Ipsita, primary, Fetter, Isobel J., primary, Baiev, Islam, primary, Van Seventer, Emily E., primary, Murphy, Janet E., primary, Ferrone, Cristina R., primary, Tanabe, Kenneth K., primary, Deshpande, Vikram, primary, Harding, James J., primary, Yaeger, Rona, primary, Kelley, Robin K., primary, Bardelli, Alberto, primary, Iafrate, A. John, primary, Hahn, William C., primary, Benes, Cyril H., primary, Ting, David T., primary, Hirai, Hiroshi, primary, Getz, Gad, primary, Juric, Dejan, primary, Zhu, Andrew X., primary, Corcoran, Ryan B., primary, and Bardeesy, Nabeel, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure 2 from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

35. Table S1 from TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Author

Goyal, Lipika, primary, Shi, Lei, primary, Liu, Leah Y., primary, Fece de la Cruz, Ferran, primary, Lennerz, Jochen K., primary, Raghavan, Srivatsan, primary, Leschiner, Ignaty, primary, Elagina, Liudmila, primary, Siravegna, Giulia, primary, Ng, Raymond W.S., primary, Vu, Phuong, primary, Patra, Krushna C., primary, Saha, Supriya K., primary, Uppot, Raul N., primary, Arellano, Ron, primary, Reyes, Stephanie, primary, Sagara, Takeshi, primary, Otsuki, Sachie, primary, Nadres, Brandon, primary, Shahzade, Heather A., primary, Dey-Guha, Ipsita, primary, Fetter, Isobel J., primary, Baiev, Islam, primary, Van Seventer, Emily E., primary, Murphy, Janet E., primary, Ferrone, Cristina R., primary, Tanabe, Kenneth K., primary, Deshpande, Vikram, primary, Harding, James J., primary, Yaeger, Rona, primary, Kelley, Robin K., primary, Bardelli, Alberto, primary, Iafrate, A. John, primary, Hahn, William C., primary, Benes, Cyril H., primary, Ting, David T., primary, Hirai, Hiroshi, primary, Getz, Gad, primary, Juric, Dejan, primary, Zhu, Andrew X., primary, Corcoran, Ryan B., primary, and Bardeesy, Nabeel, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure 4 from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Methods from Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition

Author

Harding, James J., primary, Lowery, Maeve A., primary, Shih, Alan H., primary, Schvartzman, Juan M., primary, Hou, Shengqi, primary, Famulare, Christopher, primary, Patel, Minal, primary, Roshal, Mikhail, primary, Do, Richard K., primary, Zehir, Ahmet, primary, You, Daoqi, primary, Selcuklu, S. Duygu, primary, Viale, Agnes, primary, Tallman, Martin S., primary, Hyman, David M., primary, Reznik, Ed, primary, Finley, Lydia W.S., primary, Papaemmanuil, Elli, primary, Tosolini, Alessandra, primary, Frattini, Mark G., primary, MacBeth, Kyle J., primary, Liu, Guowen, primary, Fan, Bin, primary, Choe, Sung, primary, Wu, Bin, primary, Janjigian, Yelena Y., primary, Mellinghoff, Ingo K., primary, Diaz, Luis A., primary, Levine, Ross L., primary, Abou-Alfa, Ghassan K., primary, Stein, Eytan M., primary, and Intlekofer, Andrew M., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 4 from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 1 from Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

Author

Abdel-Wahab, Omar, primary, Klimek, Virginia M., primary, Gaskell, Alisa A., primary, Viale, Agnes, primary, Cheng, Donavan, primary, Kim, Eunhee, primary, Rampal, Raajit, primary, Bluth, Mark, primary, Harding, James J., primary, Callahan, Margaret K., primary, Merghoub, Taha, primary, Berger, Michael F., primary, Solit, David B., primary, Rosen, Neal, primary, Levine, Ross L., primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

40. Data from TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Author

Goyal, Lipika, primary, Shi, Lei, primary, Liu, Leah Y., primary, Fece de la Cruz, Ferran, primary, Lennerz, Jochen K., primary, Raghavan, Srivatsan, primary, Leschiner, Ignaty, primary, Elagina, Liudmila, primary, Siravegna, Giulia, primary, Ng, Raymond W.S., primary, Vu, Phuong, primary, Patra, Krushna C., primary, Saha, Supriya K., primary, Uppot, Raul N., primary, Arellano, Ron, primary, Reyes, Stephanie, primary, Sagara, Takeshi, primary, Otsuki, Sachie, primary, Nadres, Brandon, primary, Shahzade, Heather A., primary, Dey-Guha, Ipsita, primary, Fetter, Isobel J., primary, Baiev, Islam, primary, Van Seventer, Emily E., primary, Murphy, Janet E., primary, Ferrone, Cristina R., primary, Tanabe, Kenneth K., primary, Deshpande, Vikram, primary, Harding, James J., primary, Yaeger, Rona, primary, Kelley, Robin K., primary, Bardelli, Alberto, primary, Iafrate, A. John, primary, Hahn, William C., primary, Benes, Cyril H., primary, Ting, David T., primary, Hirai, Hiroshi, primary, Getz, Gad, primary, Juric, Dejan, primary, Zhu, Andrew X., primary, Corcoran, Ryan B., primary, and Bardeesy, Nabeel, primary

Published
2023
Full Text
View/download PDF

41. Supplemental Table 2 from Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies

Author

Harding, James J., primary, Nandakumar, Subhiksha, primary, Armenia, Joshua, primary, Khalil, Danny N., primary, Albano, Melanie, primary, Ly, Michele, primary, Shia, Jinru, primary, Hechtman, Jaclyn F., primary, Kundra, Ritika, primary, El Dika, Imane, primary, Do, Richard K., primary, Sun, Yichao, primary, Kingham, T. Peter, primary, D'Angelica, Michael I., primary, Berger, Michael F., primary, Hyman, David M., primary, Jarnagin, William, primary, Klimstra, David S., primary, Janjigian, Yelena Y., primary, Solit, David B., primary, Schultz, Nikolaus, primary, and Abou-Alfa, Ghassan K., primary

Published
2023
Full Text
View/download PDF

42. Figure S2 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection

Author

Jolissaint, Joshua S., primary, Soares, Kevin C., primary, Seier, Kenneth P., primary, Kundra, Ritika, primary, Gönen, Mithat, primary, Shin, Paul J., primary, Boerner, Thomas, primary, Sigel, Carlie, primary, Madupuri, Ramyasree, primary, Vakiani, Efsevia, primary, Cercek, Andrea, primary, Harding, James J., primary, Kemeny, Nancy E., primary, Connell, Louise C., primary, Balachandran, Vinod P., primary, D'Angelica, Michael I., primary, Drebin, Jeffrey A., primary, Kingham, T. Peter, primary, Wei, Alice C., primary, and Jarnagin, William R., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Tables 1-3 from A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer

Author

Harding, James J., primary, Zhu, Andrew X., primary, Bauer, Todd M., primary, Choueiri, Toni K., primary, Drilon, Alexander, primary, Voss, Martin H., primary, Fuchs, Charles S., primary, Abou-Alfa, Ghassan K., primary, Wijayawardana, Sameera R., primary, Wang, Xuejing Aimee, primary, Moser, Brian A., primary, Uruñuela, Arantxa, primary, Wacheck, Volker, primary, and Bendell, Johanna C., primary

Published
2023
Full Text
View/download PDF

44. Figure S3 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection

Author

Jolissaint, Joshua S., primary, Soares, Kevin C., primary, Seier, Kenneth P., primary, Kundra, Ritika, primary, Gönen, Mithat, primary, Shin, Paul J., primary, Boerner, Thomas, primary, Sigel, Carlie, primary, Madupuri, Ramyasree, primary, Vakiani, Efsevia, primary, Cercek, Andrea, primary, Harding, James J., primary, Kemeny, Nancy E., primary, Connell, Louise C., primary, Balachandran, Vinod P., primary, D'Angelica, Michael I., primary, Drebin, Jeffrey A., primary, Kingham, T. Peter, primary, Wei, Alice C., primary, and Jarnagin, William R., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure 2A from A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer

Author

Harding, James J., primary, Zhu, Andrew X., primary, Bauer, Todd M., primary, Choueiri, Toni K., primary, Drilon, Alexander, primary, Voss, Martin H., primary, Fuchs, Charles S., primary, Abou-Alfa, Ghassan K., primary, Wijayawardana, Sameera R., primary, Wang, Xuejing Aimee, primary, Moser, Brian A., primary, Uruñuela, Arantxa, primary, Wacheck, Volker, primary, and Bendell, Johanna C., primary

Published
2023
Full Text
View/download PDF

46. Supplementary Figure 1 from Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

Author

Lowery, Maeve A., primary, Ptashkin, Ryan, primary, Jordan, Emmet, primary, Berger, Michael F., primary, Zehir, Ahmet, primary, Capanu, Marinela, primary, Kemeny, Nancy E., primary, O'Reilly, Eileen M., primary, El-Dika, Imane, primary, Jarnagin, William R., primary, Harding, James J., primary, D'Angelica, Michael I., primary, Cercek, Andrea, primary, Hechtman, Jaclyn F., primary, Solit, David B., primary, Schultz, Nikolaus, primary, Hyman, David M., primary, Klimstra, David S., primary, Saltz, Leonard B., primary, and Abou-Alfa, Ghassan K., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Data from Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody

Author

Harding, James J., primary, Moreno, Victor, primary, Bang, Yung-Jue, primary, Hong, Min Hee, primary, Patnaik, Amita, primary, Trigo, José, primary, Szpurka, Anna M., primary, Yamamoto, Noboru, primary, Doi, Toshihiko, primary, Fu, Siqing, primary, Calderon, Boris, primary, Velez de Mendizabal, Nieves, primary, Calvo, Emiliano, primary, Yu, Danni, primary, Gandhi, Leena, primary, Liu, Zhuqing Tina, primary, Galvao, Violeta Regnier, primary, Leow, Ching Ching, primary, and de Miguel, Maria J., primary

Published
2023
Full Text
View/download PDF

48. Supplementary Figure Legends from Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection

Author

Park, Wungki, primary, Chen, Jiapeng, primary, Chou, Joanne F., primary, Varghese, Anna M., primary, Yu, Kenneth H., primary, Wong, Winston, primary, Capanu, Marinela, primary, Balachandran, Vinod, primary, McIntyre, Caitlin A., primary, El Dika, Imane, primary, Khalil, Danny N., primary, Harding, James J., primary, Ghalehsari, Nima, primary, McKinnell, Zoe, primary, Chalasani, Sree B., primary, Makarov, Vladimir, primary, Selenica, Pier, primary, Pei, Xin, primary, Lecomte, Nicolas, primary, Kelsen, David P., primary, Abou-Alfa, Ghassan K., primary, Robson, Mark E., primary, Zhang, Liying, primary, Berger, Michael F., primary, Schultz, Nikolaus, primary, Chan, Timothy A., primary, Powell, Simon N., primary, Reis-Filho, Jorge S., primary, Iacobuzio-Donahue, Christine A., primary, Riaz, Nadeem, primary, and O'Reilly, Eileen M., primary

Published
2023
Full Text
View/download PDF

49. Supplemental Table 3 from Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies

Author

Harding, James J., primary, Nandakumar, Subhiksha, primary, Armenia, Joshua, primary, Khalil, Danny N., primary, Albano, Melanie, primary, Ly, Michele, primary, Shia, Jinru, primary, Hechtman, Jaclyn F., primary, Kundra, Ritika, primary, El Dika, Imane, primary, Do, Richard K., primary, Sun, Yichao, primary, Kingham, T. Peter, primary, D'Angelica, Michael I., primary, Berger, Michael F., primary, Hyman, David M., primary, Jarnagin, William, primary, Klimstra, David S., primary, Janjigian, Yelena Y., primary, Solit, David B., primary, Schultz, Nikolaus, primary, and Abou-Alfa, Ghassan K., primary

Published
2023
Full Text
View/download PDF

50. Figure S3 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection

Author

Jolissaint, Joshua S., primary, Soares, Kevin C., primary, Seier, Kenneth P., primary, Kundra, Ritika, primary, Gönen, Mithat, primary, Shin, Paul J., primary, Boerner, Thomas, primary, Sigel, Carlie, primary, Madupuri, Ramyasree, primary, Vakiani, Efsevia, primary, Cercek, Andrea, primary, Harding, James J., primary, Kemeny, Nancy E., primary, Connell, Louise C., primary, Balachandran, Vinod P., primary, D'Angelica, Michael I., primary, Drebin, Jeffrey A., primary, Kingham, T. Peter, primary, Wei, Alice C., primary, and Jarnagin, William R., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results